- December 13, 2021
- 2:00 PM - 3:30 PM ET
Sigourney Bell, PhD Student, Gilbertson Laboratory, CRUK – Cambridge Institute | Co-Founder -Black in Cancer | Forbes 30 under 30
Sybil Green, JD, RPh, MHA, Chief Diversity and Inclusion Officer, American Society of Clinical Oncology
Adekunle “Kunle” Odunsi, MD, Director of University of Chicago Medicine Comprehensive Cancer Center
Richard “Rick” Pazdur, MD, Oncology Center of Excellence Director, FDA
Norman “Ned” Sharpless, MD, National Cancer Institute Director, NIH
Pratik Yarlagadda, Student | Oncology Center of Excellence Summer Scholar Alumnus
Moderator: Rea Blakey, Associate Director for External Outreach and Engagement, Oncology Center of Excellence, FDA
Registration required to attend: https://www.surveymonkey.com/r/OCE_CoCa_12132021
The FDA Oncology Center of Excellence (OCE) joins the entire cancer community in recognizing the 50th anniversary of the National Cancer Act. The Conversations on Cancer public panel discussion “50 Years and Counting: Engaging the Generations on Future Cancer Equity Opportunities” will address important cancer drug development achievements during the last five decades. The discussion will feature some of the nation’s leading cancer experts focusing on the promise of cancer research and cancer equity for future generations of patients and families.
“50 Years and Counting: Engaging the Generations on Future Cancer Equity Opportunities” also marks the official conclusion of the 2021 OCE Project Community initiative known as National Black Family Cancer Awareness Week. The initiative and #BlackFamCan social media campaign began in 2021 coinciding with the 50th anniversary of the National Cancer Act, and the signing of Presidential Executive Order 13985, “Advancing Racial Equity and Support for Underserved Communities Through the Federal Government.” Plans for the 2022 #BlackFamCan social media campaign will be announced during the December 13 Conversations on Cancer public panel discussion.
A free-of-charge webcast of this public panel discussion will be provided. Registration for the webcast is required at the link above.
FDA plans to post archived webcasts after the meeting, however, in cases where the transmission was not successful, archived webcasts will not be available.
For any inquiries regarding this program, please send an email to: OCE-Engagement@fda.hhs.gov